Povidone iodine has broad antimicrobial activity,works against biofilms, and has effect on inflammation. It can be used for management and treatment of acute and chronic wounds.Betadine is an over the counter (OTC) medication. It has not been tested and approved by the FDA, however, it complies with applicable regulations and policies.
MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 Known serious all to tirzepatide or any of the excipients in MOUNJARO ...
I really want to thank the author for such a nice blog that helped me to understand why it is important. Povidone Iodine Manufacturer
ReplyDeleteExtremely useful information which you have shared here. This is a great way to enhance knowledge for us, and also helpful for us. Thankful to you for sharing an article like this. complete pharmacovigilance solutions
ReplyDelete